The global Nonsteroidal Anti-Inflammatory Drugs (NSAID) market is witnessing robust expansion, driven by rising chronic pain conditions, an aging population, and a shift toward non-opioid pain management solutions. According to The Insight Partners report, the market size is projected to grow from US$ 24.82 billion in 2024 to US$ 38.38 billion by 2031, registering a compound...